A detailed history of Bay Harbor Wealth Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bay Harbor Wealth Management, LLC holds 3 shares of HRMY stock, worth $102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 2 50.0%
Holding current value
$102
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

BUY
$26.76 - $38.05 $26 - $38
1 Added 50.0%
3 $0
Q2 2025

Jul 22, 2025

BUY
$27.94 - $35.91 $27 - $35
1 Added 100.0%
2 $0
Q1 2025

May 12, 2025

BUY
$32.18 - $40.46 $32 - $40
1 New
1 $0

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Bay Harbor Wealth Management, LLC Portfolio

Follow Bay Harbor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.